Supreme Court Report

Supreme Court of the United States · Official docket →

Namir White v. United States

IFP petition · United States Court of Appeals for the Third Circuit, No. 22-1179 · judgment December 18, 2025


Certiorari denied · June 1, 2026

Question presented

Under the federal Sentencing Guidelines § 2K2.1(a)(2), a defendant previously convicted of a “controlled substance offense” is subject to a sentencing enhancement. The Guidelines define “controlled substance offense” as “an offense under federal or state law * * * that prohibits the manufacture, import, export, distribution, or dispensing of a controlled substance.” U.S.S.G. § 4B1.2(b) (emphasis added); see id. § 2K2.1 application note 1. The Guidelines do not, however, define “controlled substance.” When a federal defendant is subject to a controlled substance enhancement under the Sentencing Guidelines, does the term “controlled substance” in the Sentencing Guidelines refer only to those substances controlled under federal law or also include substances controlled under state law?

Counsel of record

For petitioner
Richard Coughlin
Richard Coughlin, Esq., LLC

For respondent
D. John Sauer
Solicitor General

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Jun 01 2026
    Petition DENIED.
  2. May 13 2026
    DISTRIBUTED for Conference of 5/28/2026.
  3. Apr 27 2026
    Brief of respondent United States in opposition filed.
  4. Mar 23 2026
    Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2026.
  5. Mar 20 2026
    Motion to extend the time to file a response from March 27, 2026 to April 27, 2026, submitted to The Clerk.
  6. Feb 20 2026
    Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due March 27, 2026)